Guangzhou SIG Biomedical Technology Co., Ltd.
Guangzhou SIG Biomedical Technology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Phase I Study of SIG001 Antibody on Cancer Therapy. | Neoplams | Not yet recruiting | Phase 1 | 2026-03-20 | NCT07486700 |